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CC BY-NC-ND license (http://creativeAbstract Irrespective of positive developments of cancer treatment, the mortality due to
various cancers remains high and the mechanisms of cancer initiation and the development
also remains mysterious. As we know that microRNAs are considered to be a short noncoding
RNA molecules consisting of 21e25 nucleotides (nt) in length and they silence their target
genes by inhibiting mRNA translation or degrading the mRNA molecules by binding to their
30-untranslated (UTR) region and play a very important role in cancer biology. Recent evi-
dences indicate that miR-21 is over expressed in cancer stem cells and plays a vital role in cell
proliferation, apoptosis, and invasion. Even though an increased expression level of miR-21 has
been observed in cancer stem cells, studies related to the role of miR-21 in cancer stem cells
are limited. The main aim of this mini review is to explain the potency of miR-21 in various
cancer stem cells (CSCs) and as a new target for therapeutic interventions of cancer progres-
sion.
Copyright ª 2016, Chongqing Medical University. Production and hosting by Elsevier B.V. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).search Centre, Narayana Medical College and Hospital, Chinthareddypalem, Nellore, India. Tel.:
om (D. Sekar).
f Chongqing Medical University.
16.05.002
ng Medical University. Production and hosting by Elsevier B.V. This is an open access article under the
commons.org/licenses/by-nc-nd/4.0/).
278 D. Sekar et al.Introduction
Cancer stem cells (CSCs) are considering being an important
cells and consistently reported in many malignancies. They
are frequently associated with initiation and progression of
various tumours. Interestingly, CSCs and normal somatic
stem cells share many biological properties such as self-
renewal and the nature of differentiation but they have
differences in metastatic activity and other characters.
Consistence evidences suggested that CSCs have potential
clinical importance, but the regulation at the molecular
level is not well-understood.1 As we know that CSCs are
resistant to various drugs and they are considered to
important cells clinical practice. It is important to know
that characteristics of CSCs and the discovery of thera-
peutic agents that targeting CSCs are most valuable in
cancer research.2,3
MicroRNAs (miRNAs) are considered to be an endogenous
non-coding RNAs played variety of role in several cancers.
Recent evidences are shows that miRNAs can regulate the
CSCs at a molecular level and are associated with cancer
initiation and metastasis.4,5 As we know that microRNAs are
consider to be a short noncoding RNA molecules consisting
of 21e25 nucleotides (nt) in length and they silence their
target genes by inhibiting mRNA translation or degrading
the mRNA molecules by binding to their 30-untranslated
(UTR) region and plays a very important role in cancer
biology.4
microRNA 21, also known as hsa-mir-21 is encoded by the
miR-21 gene located on chromosome 17q23.2 immediately
downstream of the vacuole membrane protein-1 (VMP1)
gene.4,6 miR-21 is one of the common microRNA that is
frequently upregulated in a variety of cancers including
breast,7 ovaries,8 cervix,9 colon,10 lung11 and liver.12 miR-21
is also an oncogenic miRNA that can modulate the expres-
sion of multiple tumour suppressor genes such as Phospha-
tase and Tensin homolog (PTEN), Serpini1, and programmed
cell death 4 protein (PDCD4).13,14 Expectedly, inhibition of
miR-21 through anti-miR-21 resulted in cell growth inhibi-
tion, increased apoptosis and decreased cell proliferation.
Recent reports show that miR-21 and their networks play
critical roles in regulating CSCs growth differentiation in the
colon cancer and progression of chemo-resistance.15
Consistently, miR-21 plays an important role in regulating
stemness by modulating TGFbR2 signalling in colon cancer
cells.10 Inhibition of miR-21 can inhibit tumour growth
through elevating PTEN, SNX1, and SGPP1 expression and
inhibiting Akt phosphorylation in lung cancer like cells.10
Interestingly, aberrantly expressed miR-21 regulates
CSCs apoptosis and proliferation partly through directly
down-regulating FASLG protein expression in Glioblastoma
Cancer Stem Cells (GSCs) and this may be a potential
therapeutic target for glioblastoma.16 From the above
points, we know that miR-21 is consistently involved in the
various kinds of CSCs and Up to date, there is no review
demonstrating the role of miR-21 in cancer stem cells and
the number of studies related to miR-21 in CSCs is limited.
Therefore, the main thrust of this mini review is to provide
clinical evidence and significance of miR-21 in CSCs. We are
also summarizing the important research findings sur-
rounding the role of miR-21 in CSCs.Role of miR-21 in different types of cancer
stem cells (CSCs)
Recent reports suggested that miR-21 functions have been
linked to cancer progression and chemo resistance.17 In the
same study it has been reported that the role of miR-21 as
an oncogenic regulator in stem/progenitor cell populations
that is involved in the promotion of the cellular trans-
formation process and chemotherapy resistance. It is very
clear that there are several potential mechanisms by which
miR-21 might promote cancer stem/progenitor populations,
miR-21 in non-progenitor cancer cells could produce growth
factors that enrich stem cell populations, secondly, miR-21
in the cancer progenitor cell niche might directly regulate
progenitor cells to self-renew and finally miR-21 in certain
non-progenitor cancer cells may trigger a dedifferentiation
process, so enriching stem cell populations.17
Recent study reported that among other miRNAs, miR-21
is the most reported miRNAs in colon CSCs regulation.
Additionally, it has been reported to act on processes
involving CSCs through cell cycle regulation genes and epi-
thelialemesenchymal transition.18 Interestingly, in
Anaplastic Thyroid carcinoma (ATC) therapy, the knockdown
of miR-21 significantly changed the expression pattern
certain genes such as of PDCD4, p21, Oct-4, ABCG2, and Mcl-
1 suggesting that miR-21, as an oncomiR, controls stemness
and tumour growth, differentiation, and apoptosis.19
Another study with CSCs showed that the expression of
miR-21 to be greatly increased and miR-145 decreased in
colon cancer cells that are highly enriched in CSC. They
found that expression pattern of miR-145 in colon cancer
cells greatly inhibits CSCs and tumour growth, whereas up-
regulation of miR-21 induce CSCs and tumour growth. In
addition, administration of mature miR-145 or antagomir-
21 (anti-sense miR-21) greatly suppresses the growth of
colon cancer cell xenografts in SCID mice and their in vitro
studies also demonstrated that miR-21 negatively regulates
miR-145 and vice versa, suggesting that miR-21, miR-145,
and their networks play critical roles in regulating CSCs
growth and/or differentiation in the colon cancer and
progression of chemo-resistance.15
It has been revealed that miR-21 increased significantly
in glioblastoma brain tissue, and it is up-regulated in glio-
blastoma cancer stem cells (GSCs) remarkably, suggesting
that aberrantly expressed miR-21 regulates GSCs apoptosis
and proliferation partly through directly down-regulating
FASLG protein expression in GSCs and this might offer a new
potential therapeutic stratagem for glioblastoma.16 We
know that resistance of cancer stem/progenitor cells
(CSPCs) to chemotherapy can lead to cancer relapse.
Ovarian terato carcinoma (OVTC) arises from germ cells and
comprises pluripotent cells that can be used to study can-
cer cell stemness. Knockdown of miR-21 resulted in a
marked reduction in the CD133 þ population and sphere
formation of CSPCs. Contrastingly, overexpression of miR-
21 resulted in a marked increase in the population of
CD133 þ cells as well as sphere formation of CSPCs. The
above result clearly indicates that microRNA-21 plays a
vital role in cancer growth by regulating stemness in cancer
cells20 and Table 1 describes the role of miR-21 in different
types of CSCs.
Table 1 Represents the regulations of miR-21 in various cancer stem cells (CSCs).
Types of CSCs Status of miR-21 Gene target References
Glioblastoma
Cancer Stem (GSCs)
Upregulated FASLG Shang C et al 2015
Lung cancer stem like cells Upregulated PTEN, SNX1, and SGPP1 Zhang J et al 2015
Colon CSCs Upregulated Wnt/B-catenin and Notch
signalling pathways
Mamoori A et al 2016
Anaplastic Thyroid
Carcinoma (ATC)
Upregulated PDCD4, p21, Oct-4, ABCG2, and Mcl-1 Haghpanah V et al 2015
Colon CSCs Upregulated Yu Y et al 2015
Cancer Stem/Progenitor
Cells (CSPCs)
Upregulated CD133þ Chung WM et al 2013
Hepatocellular
Carcinoma (HCC)
Upregulated Zhou L et al 2013
Paediatric cancer (CSCs) Upregulated Sanchez-Diaz PC et al 2013
Glioblastoma
Cancer Stem (GSCs)
Upregulated Zhang S et al 2012
Cancer Stem Cells (CSCs) Upregulated EMT Markers (N-cadherin, Vimentin,
alpha-smooth muscle actin and E-cadherin
Han M et al 2012
Deciphering the role of microRNA 21 279From the literature studies, we know that CSCs may be
involved in metastasis formation and side population (SP)
cells isolated from diverse cancer cells possess stem cell-
like properties. Interestingly, the aberrant expression of
miR-21 in SP cells showed that it regulates the expression of
multiple target proteins that are associated with tumour
dissemination. miR-21 is a pro-metastatic miRNA in SP cells
and raises the possibility that therapy of hepatocellular
carcinoma (HCC) may be improved by pharmaceutical
strategies directed towards miR-21.21 Knocking down hsa-
miR-21-5p using antisense oligonucleotides and small
interfering RNA in cell lines led to the depletion of the CSCs
fraction and impairment of sphere formation (CSC surro-
gate assays) suggesting that CSCs associated with miR-21
and the putative pathways may have potential therapeu-
tic applications in paediatric cancers.22
It has been known that several miRNAs recently reported
in the modulation of glioma development, especially some
upregulated miRNAs, such as miR-21, which has been found
to function as an oncogene in cultured glioblastoma
multiform cells. miR-21 inhibitor or TMZ could not induce
apoptosis on GSCs. However, miR-21 inhibitor combined
with TMZ significantly enhanced GSCs apoptosis suggesting
that combination of miR-21 inhibitor and TMZ could be an
effective therapeutic strategy for GSC apoptosis to prevent
potential glioblastoma recurrence.23 Recent study shows
that the induction of epithelialemesenchymal transition
(EMT) phenotype and acquisition of cancer stem cell (CSC)
characteristics are highly interrelated, usually EMT was
assessed by overexpression of mesenchymal cell markers
(N-cadherin, Vimentin, alpha-smooth muscle actin [a-SMA])
and suppression of epithelial cell marker (E-cadherin), so
they demonstrated that the formation of CSC-like cells
usually undergo the process of EMT which are mainly
regulated by miR-21.24 Interestingly, recent studies show
that cancers may originate from special cells named cancer
stem cells (CSCs) and miRNAs have a prominent role in
regulating cellular activities. Real-time RT-PCR analysis
demonstrated an increase in mir-21 expression level in CSCsrelative to cancer cells and it may be promising objects for
targeting CSCs specifically and efficiently.25 Fig. 1 repre-
sents regulation of miR-21 in CSCs.
It has been revealed that miR-21 is known to play a key
role in the development and progression of breast cancer.
Re-expression of miR-21 induced the acquisition of EMT
phenotype by activation of mesenchymal cell markers (N-
cadherin, Vimentin, a-SMA) and inhibition of epithelial cell
marker (E-cadherin) in MCF-7/miR-21 cells, which consis-
tent with increased cell subpopulation expressing CSCs
surface markers (ALDH1(þ) and CD44(þ)/CD24(-/low)) and
the capacity of sphere forming (mammospheres).26
MicroRNA-21 (miR-21) and its upstream regulator activator
Protein-I (AP-1), composed of c-Jun and c-Fos family tran-
scription factors, were found to be frequently upregulated
in SP cells which harbours many cancer stem cell (CSC)-like
properties. Specific inhibition of miR-21 by an anti-miR-21
locked nucleic acid increased drug sensitivity and
decreased colony forming ability in CSCs.27 Recently, it has
been suggesting that miR-21 plays an important role in
regulating stemness by modulating TGFbR2 signalling in
colon cancer cells.10Clinical significance and future perspectives
Accumulating evidence suggesting that miRNAs are a broad
class of small non-coding RNAs that control expression of
complementary target messenger RNAs28 and dysregulation
of miRNAs has been described in various diseases including
cancer. From the literature it has been known that a
particular miRNA that was consistently reported to be
upregulated in various kind of cancer is miR-21. miR-21
exerts oncogenic activity in various cancer cells including
CSCs and therefore is considered as an oncomir. Consis-
tently, from the above evidence suggesting that miR-21 is
an important oncogene, which plays a significant role in the
regulation of CSCs. There are so many ways to inhibit miR-
21 such as antisense-mediated inhibition of miRNAs or anti
Fig. 1 Represents the regulation of miR-21 in cancer stem cells (CSCs).
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miRNA oligonucleotides (AMOs) deliver an effective inhibi-
tion of miRNAs in cell culture as well as in xenograft mouse
models. Additionally, it has been demonstrated that tar-
geting miR-21 by AMOs in breast cancer and glioblastoma
has been achieved for in vitro and xenograft mice
model.14,29,30 Although there is an evidence to stop miR-21
function but still, we need to have future validation for the
above studies in order to prove that AMOs can function as
therapeutic agents against CSCs, therefore it is important
to have future functional studies on miR-21 and its regu-
latory elements/regulators in relation to various kinds of
CSCs.Conclusion
Cancer stem cells (CSCs) are considered to be a cancer cells
that possess characteristics associated with normal stem
cells and consistent evidence suggesting that miRNAs and
CSCs have huge relationship to induce or repress cancer
cells. MicroRNAs regulate various CSCs, through oncogenic
and tumour suppressive proteins with signalling pathways.
miR-21 considered to be an important miRNA frequently
involved in wide varieties of CSCs. Inhibition of miR-21
decreased cell proliferation induced apoptosis and inhibi-
ted tumour growth in a number of CSCs indicated that miR-
21 plays an important role in cancer progressions through
CSCs. From the above evidences, high expression level of
miR-21 is widely believed to be associated with CSCs and
tumour growth however further investigations is still need
in animal models and patient samples. Further studies are
also required to elucidate the mechanism by which miR-21,
its emerging targets impact and validate its usefulness asprognostic and diagnostic biomarker for various kinds of
CSCs.
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